Systemic immune-inflammatory index predict short-term outcome in recurrent/metastatic and locally advanced cervical cancer patients treated with PD-1 inhibitor

Systemic immune-inflammatory index predict short-term outcome in recurrent/metastatic and locally advanced cervical cancer patients treated with PD-1 inhibitor

Abstract This study aims to assess the predictive value of certain markers of inflammation in patients with locally advanced or recurrent/metastatic cervical cancer who are undergoing treatment with anti-programmed death 1 (PD-1) therapy. A total of 105 patients with cervical cancer, who received tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Qingqing Chen, Baoqian Zhai, Jingjing Li, Hui Wang, Zhengcao Liu, Runjun Shi, Haohao Wu, Yingying Xu, Shengjun Ji
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Cervical cancer
Immunotherapy
Inflammatory markers
Prognosis
Online Access:https://doi.org/10.1038/s41598-024-82976-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-82976-6

Similar Items